High Throughput Multiplex SNP-analysis in Chronic Obstructive Pulmonary Disease and Lung Cancer

Author(s): Zsuzsanna Elek, Zsuzsanna Kovács, Gergely Keszler, Miklós Szabó, Eszter Csanky, Jane Luo, András Guttman, Zsolt Rónai*

Journal Name: Current Molecular Medicine

Volume 20 , Issue 3 , 2020


  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: A number of human inflammatory diseases and tumors have been shown to cause alterations in the glycosylation pattern of plasma proteins in a specific manner. These highly variable and versatile post-translational modifications finetune protein functions by influencing sorting, folding, enzyme activity and subcellular localization. However, relatively little is known about regulatory factors of this procedure and about the accurate causative connection between glycosylation and disease.

Objective: The aim of the present study was to investigate whether certain single nucleotide polymorphisms (SNPs) in genes encoding glycosyltransferases and glycosidases could be associated with elevated risk for chronic obstructive pulmonary disease (COPD) and lung adenocarcinoma.

Methods: A total of 32 SNPs localized in genes related to N-glycosylation were selected for the association analysis. Polymorphisms with putative biological functions (missense or regulatory variants) were recruited. SNPs were genotyped by a TaqMan OpenArray platform. A single base extension-based method in combination with capillary gel electrophoresis was used for verification.

Results: The TaqMan OpenArray approach provided accurate and reliable genotype data (global call rate: 94.9%, accuracy: 99.6%). No significant discrepancy was detected between the obtained and expected genotype frequency values (Hardy–Weinberg equilibrium) in the healthy control sample group in case of any SNP confirming reliable sampling and genotyping. Allele frequencies of the rs3944508 polymorphism localized in the 3’ UTR of the MGAT5 gene significantly differed between the sample groups compared.

Conclusion: Our results suggest that the rs34944508 SNP might modulate the risk for lung cancer by influencing the expression of MGAT5. This enzyme catalyzes the addition of N-acetylglucosamine (GlcNAc) in beta 1-6 linkage to the alpha-linked mannose of biantennary N-linked oligosaccharides, thus, increasing branching that is the characteristic of invasive malignancies.

Keywords: SNP, single-base primer extension, capillary gel electrophoresis, TaqMan OpenArray, lung adenocarcinoma, COPD, genetic association.

[1]
Jayaprakash NG, Surolia A. Role of glycosylation in nucleating protein folding and stability. Biochem J 2017; 474(14): 2333-47.
[http://dx.doi.org/10.1042/BCJ20170111] [PMID: 28673927]
[2]
Peixoto A, Relvas-Santos M, Azevedo R, Santos LL, Ferreira JA. Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks. Front Oncol 2019; 9: 380.
[http://dx.doi.org/10.3389/fonc.2019.00380] [PMID: 31157165]
[3]
Bassagañas S, Allende H, Cobler L, et al. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines. Cytokine 2015; 75(1): 197-206.
[http://dx.doi.org/10.1016/j.cyto.2015.04.006] [PMID: 25934648]
[4]
Zoldoš V, Novokmet M, Bečeheli I, Lauc G. Genomics and epigenomics of the human glycome. Glycoconj J 2013; 30(1): 41-50.
[http://dx.doi.org/10.1007/s10719-012-9397-y] [PMID: 22648057]
[5]
B S GK. Mohan Reddy P, Kottekad S. Comparative site-specific N-glycosylation analysis of lactoperoxidase from buffalo and goat milk using RP-UHPLC-MS/MS reveals a distinct glycan pattern. J Agric Food Chem 2018; 66(43): 11492-9.
[http://dx.doi.org/10.1021/acs.jafc.8b03243] [PMID: 30296068]
[6]
Lageveen-Kammeijer GSM, de Haan N, Mohaupt P, et al. Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples. Nat Commun 2019; 10(1): 2137.
[http://dx.doi.org/10.1038/s41467-019-09910-7] [PMID: 31086181]
[7]
Goulabchand R, Vincent T, Batteux F, Eliaou JF, Guilpain P. Impact of autoantibody glycosylation in autoimmune diseases. Autoimmun Rev 2014; 13(7): 742-50.
[http://dx.doi.org/10.1016/j.autrev.2014.02.005] [PMID: 24657512]
[8]
Huang C, Zhan T, Liu Y, et al. Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue. Clin Proteomics 2015; 12(1): 17.
[http://dx.doi.org/10.1186/s12014-015-9088-3] [PMID: 26157355]
[9]
Kovacs Z, Simon A, Szabo Z, et al. Capillary electrophoresis analysis of N-glycosylation changes of serum paraproteins in multiple myeloma. Electrophoresis 2017; 38(17): 2115-23.
[http://dx.doi.org/10.1002/elps.201700006] [PMID: 28116769]
[10]
Tozawa-Ono A, Kubota M, Honma C, et al. Glycan profiling using formalin-fixed, paraffin-embedded tissues: Hippeastrum hybrid lectin is a sensitive biomarker for squamous cell carcinoma of the uterine cervix. J Obstet Gynaecol Res 2017; 43(8): 1326-34.
[http://dx.doi.org/10.1111/jog.13359] [PMID: 28585749]
[11]
Ceciliani F, Pocacqua V. The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases. Curr Protein Pept Sci 2007; 8(1): 91-108.
[http://dx.doi.org/10.2174/138920307779941497] [PMID: 17305563]
[12]
Novokmet M, Lukić E, Vučković F, et al. Changes in IgG and total plasma protein glycomes in acute systemic inflammation. Sci Rep 2014; 4: 4347.
[http://dx.doi.org/10.1038/srep04347] [PMID: 24614541]
[13]
Theodoratou E, Campbell H, Ventham NT, et al. The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 2014; 11(10): 588-600.
[http://dx.doi.org/10.1038/nrgastro.2014.78] [PMID: 24912389]
[14]
Drabik A, Bodzon-Kulakowska A, Suder P, Silberring J, Kulig J, Sierzega M. Glycosylation changes in serum proteins identify patients with pancreatic cancer. J Proteome Res 2017; 16(4): 1436-44.
[http://dx.doi.org/10.1021/acs.jproteome.6b00775] [PMID: 28244758]
[15]
Krishnan S, Whitwell HJ, Cuenco J, et al. Evidence of altered glycosylation of serum proteins prior to pancreatic cancer diagnosis. Int J Mol Sci 2017; 18(12): E2670
[http://dx.doi.org/10.3390/ijms18122670] [PMID: 29232830]
[16]
Choi JW, Moon BI, Lee JW, Kim HJ, Jin Y, Kim HJ. Use of CA153 for screening breast cancer: An antibodylectin sandwich assay for detecting glycosylation of CA153 in sera. Oncol Rep 2018; 40(1): 145-54.
[http://dx.doi.org/10.3892/or.2018.6433] [PMID: 29749490]
[17]
Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, et al. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls. Biochem Biophys Res Commun 2016; 469(4): 1140-5.
[http://dx.doi.org/10.1016/j.bbrc.2015.12.114] [PMID: 26740182]
[18]
Ruhaak LR, Kim K, Stroble C, et al. Protein-specific differential glycosylation of immunoglobulins in serum of ovarian cancer patients. J Proteome Res 2016; 15(3): 1002-10.
[http://dx.doi.org/10.1021/acs.jproteome.5b01071] [PMID: 26813784]
[19]
Weiz S, Wieczorek M, Schwedler C, et al. Acute-phase glycoprotein N-glycome of ovarian cancer patients analyzed by CE-LIF. Electrophoresis 2016; 37(11): 1461-7.
[http://dx.doi.org/10.1002/elps.201500518] [PMID: 26763099]
[20]
Kazuno S, Fujimura T, Arai T, et al. Multi-sequential surface plasmon resonance analysis of haptoglobin-lectin complex in sera of patients with malignant and benign prostate diseases. Anal Biochem 2011; 419(2): 241-9.
[http://dx.doi.org/10.1016/j.ab.2011.08.029] [PMID: 21907698]
[21]
Ju L, Wang Y, Xie Q, et al. Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer. Glycobiology 2016; 26(5): 460-71.
[http://dx.doi.org/10.1093/glycob/cwv117] [PMID: 26646445]
[22]
Mondal G, Saroha A, Bose PP, Chatterjee BP. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients. Glycoconj J 2016; 33(2): 209-18.
[http://dx.doi.org/10.1007/s10719-016-9658-2] [PMID: 27034286]
[23]
de Andrade M, Li Y, Marks RS, et al. Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. Cancer Prev Res (Phila) 2012; 5(3): 365-73.
[http://dx.doi.org/10.1158/1940-6207.CAPR-11-0243] [PMID: 22044695]
[24]
Ayyub A, Saleem M, Fatima I, Tariq A, Hashmi N, Musharraf SG. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker. Int J Biochem Cell Biol 2016; 70: 68-75.
[http://dx.doi.org/10.1016/j.biocel.2015.11.006] [PMID: 26563422]
[25]
Liang Y, Ma T, Thakur A, et al. Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer. Glycobiology 2015; 25(3): 331-40.
[http://dx.doi.org/10.1093/glycob/cwu115] [PMID: 25347993]
[26]
Togayachi A, Iwaki J, Kaji H, et al. Glycobiomarker, fucosylated short-form secretogranin iii levels are increased in serum of patients with small cell lung carcinoma. J Proteome Res 2017; 16(12): 4495-505.
[http://dx.doi.org/10.1021/acs.jproteome.7b00484] [PMID: 28949141]
[27]
Váradi C, Mittermayr S, Szekrényes Á, et al. Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung diseases by capillary electrophoresis. Electrophoresis 2013; 34(16): 2287-94.
[http://dx.doi.org/10.1002/elps.201300041] [PMID: 23580236]
[28]
Phelan CM, Tsai YY, Goode EL, et al. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2010; 19(2): 600-4.
[http://dx.doi.org/10.1158/1055-9965.EPI-09-0861] [PMID: 20142253]
[29]
Kovacs-Nagy R, Elek Z, Szekely A, Nanasi T, Sasvari-Szekely M, Ronai Z. Association of aggression with a novel microRNA binding site polymorphism in the wolframin gene. Am J Med Genet B Neuropsychiatr Genet 2013; 162(4): 404-12.
[30]
Elek Z, Németh N, Nagy G, et al. Micro-RNA Binding Site Polymorphisms in the WFS1 Gene Are Risk Factors of Diabetes Mellitus. PLoS One 2015; 10(10): e0139519
[http://dx.doi.org/10.1371/journal.pone.0139519] [PMID: 26426397]
[31]
Srinivasan S, Stephens C, Wilson E, et al. Prostate cancer risk-associated single-nucleotide polymorphism affects prostate-specific antigen glycosylation and its function. Clin Chem 2019; 65(1): e1-9.
[http://dx.doi.org/10.1373/clinchem.2018.295790] [PMID: 30538125]
[32]
Vajaria BN, Patel PS. Glycosylation: a hallmark of cancer? Glycoconj J 2017; 34(2): 147-56.
[http://dx.doi.org/10.1007/s10719-016-9755-2] [PMID: 27975160]
[33]
Banlaki Z, Elek Z, Nanasi T, et al. Polymorphism in the serotonin receptor 2a (HTR2A) gene as possible predisposal factor for aggressive traits. PLoS One 2015; 10(2): e0117792
[http://dx.doi.org/10.1371/journal.pone.0117792] [PMID: 25658328]
[34]
Elek Z, Dénes R, Prokop S, et al. Multicapillary gel electrophoresis based analysis of genetic variants in the WFS1 gene. Electrophoresis 2016; 37(17-18): 2313-21.
[http://dx.doi.org/10.1002/elps.201600251] [PMID: 27377286]
[35]
Zhou F, Wang W, Xing Y, Wang T, Xu X, Wang J. NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells. Biochim Biophys Acta 2014; 1839(4): 344-54.
[http://dx.doi.org/10.1016/j.bbagrm.2014.01.006] [PMID: 24418602]
[36]
Satoh J, Kino Y, Niida S. MicroRNA-seq data analysis pipeline to identify blood biomarkers for Alzheimer’s disease from public data. Biomark Insights 2015; 10: 21-31.
[http://dx.doi.org/10.4137/BMI.S25132] [PMID: 25922570]
[37]
Groen K, Maltby VE, Lea RA, et al. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis. BMC Med Genomics 2018; 11(1): 48.
[http://dx.doi.org/10.1186/s12920-018-0365-7] [PMID: 29783973]
[38]
Zhou X, Chen H, Wang Q, Zhang L, Zhao J. Knockdown of Mgat5 inhibits CD133+ human pulmonary adenocarcinoma cell growth in vitro and in vivo. Clin Invest Med 2011; 34(3): E155-62.
[http://dx.doi.org/10.25011/cim.v34i3.15188] [PMID: 21631992]
[39]
Nagae M, Kizuka Y, Mihara E, et al. Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V. Nat Commun 2018; 9(1): 3380.
[http://dx.doi.org/10.1038/s41467-018-05931-w] [PMID: 30140003]
[40]
Huang W, Luo WJ, Zhu P, et al. Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation. Biochem J 2013; 449(2): 437-48.
[http://dx.doi.org/10.1042/BJ20120343] [PMID: 23005037]
[41]
Ferdosi S, Rehder DS, Maranian P, et al. Stage dependence, cell-origin independence, and prognostic capacity of serum glycan fucosylation, β1-4 branching, β1-6 branching, and α2-6 sialylation in cancer. J Proteome Res 2018; 17(1): 543-58.
[http://dx.doi.org/10.1021/acs.jproteome.7b00672] [PMID: 29129073]
[42]
Bubka M, Link-Lenczowski P, Janik M, Pocheć E, Lityńska A. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation. Biochimie 2014; 103: 37-49.
[http://dx.doi.org/10.1016/j.biochi.2014.04.003] [PMID: 24726881]
[43]
Liu J, Liu H, Zhang W, et al. N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation. Glycobiology 2013; 23(9): 1097-109.
[http://dx.doi.org/10.1093/glycob/cwt049] [PMID: 23811795]
[44]
Chiang WF, Cheng TM, Chang CC, et al. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation. Oncogene 2018; 37(1): 116-27.
[http://dx.doi.org/10.1038/onc.2017.303] [PMID: 28892050]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 3
Year: 2020
Published on: 10 February, 2020
Page: [185 - 193]
Pages: 9
DOI: 10.2174/1566524019666191017123446
Price: $65

Article Metrics

PDF: 24
HTML: 5